Clinical trial
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
NCT02440789 is registered in ClinicalTrials.gov with Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
- Lead sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 21, 2015
- Completion date
- February 1, 2018
- Enrollment
- 32 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1 infection